Coste Catherine 4
4 · BIOMERICA INC · Filed Jan 30, 2023
Insider Transaction Report
Form 4
BIOMERICA INCBMRA
Coste Catherine
Director
Transactions
- Purchase
Common Stock
2023-01-26$2.96/sh+2,190$6,482→ 43,790 total
Footnotes (1)
- [F1]Open Market Purchase